Kura Oncology
Kura Oncology is seeking a Scientist to support its Precision Medicine Team in executing biomarker studies across clinical trials for cancer therapeutics. The role involves collaborative efforts across departments to generate high-quality biomarker data that supports drug development, with a focus on genomic, transcriptomic, or proteomic data analysis.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2014
Kura Oncology is a precision oncology biotechnology company focused on realizing the promise of targeted medicines to help patients with cancer lead better, longer lives. The company discovers and develops small-molecule therapies designed to inhibit specific cancer-driving pathways and genetic alterations, advancing programs through preclinical and clinical development. Kura works with clinical investigators and partners to test its candidates in genetically defined patient populations with the goal of delivering meaningful, durable treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Kura Oncology.
83% above the average for this role
Kura Oncology Inc. Q4 Loss Increases
1 week ago
Principal Scientist, Precision Medicine (Biomarker) Strategy Lead
Regeneron Pharmaceuticals
Senior Scientist II, Precision Medicine Translational Research Immunology
AbbVie
Senior Scientist I, Precision Medicine Oncology Genomics
AbbVie
Director, Oncology Translational Research
Diversity Employment
Director, Oncology Translational Research
Diversity Employment
Senior Scientist I, Precision Medicine Oncology Genomics
AbbVie